AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's . View the basic ABBV stock chart on Yahoo Finance. Change the date range, chart type and compare ABBVIE INC against other companies. AbbVie Inc. stock price, stock quotes and financial overviews from MarketWatch.
) AbbVie Inc. (ABBV
Fortunately, a few high-growth stocks also fall into the "undervalued stocks" category. The following equities constitute some of the best stocks for combining growth with value: It constitutes what was once Abbott's pharma division. ABBV stock has suffered in recent months as its old blockbuster drug, Humira, faces patent expirations in many countries. However, AbbVie's drug pipeline has received favorable reviews.
For this reason, most analysts believe that a new drug or a combination of future best sellers will more than replace the income lost from generic versions of Humira. Still, due to the uncertainty, ABBV stock trades at only 8. They also believe the average increase will come in at almost ABBV also offers one key benefit stemming from its former association with Abbott -- dividend aristocrat status.
Walking away from its year streak of payout hikes would put ABBV stock at risk. Hence, one can assume the increases will continue. Given the pressure to raise dividend payments every year, this is a remarkable show of confidence. Moreover, thanks to a lower stock price and higher dividends, the yield now stands at 5. Investing in ABBV stock now involves some faith. AAPL might seem like a strange choice for a high-growth stocks list.
Indeed, both the stock and the earnings projection saw a considerable move lower as iPhone sales fell well short of initial estimates. Also, laws of mathematics weigh on growth. However, as smartphone prices fall, Apple is working to make itself less iPhone-dependent. It no longer reports iPhone unit sales. Moreover, moves into services and healthcare should bring new sources of revenue.
Due to tepid iPhone sales, profit growth for the year will come in at only 0. But it should reclaim its high-growth status assuming the predicted Although one can place almost every marijuana equity in the "high-growth stocks" category right now, CannTrust stands out with its consistent profitability.
Once that listing occurs, more traders can buy it, so it should see some increase at that time. As most know, the Canadian marijuana boom came to an abrupt end in October when the product gained full legal status in Canada.
However, legalization of one form of cannabis, hemp, has reignited this boom south of the Canadian border. CGC have already recovered most of the losses which occurred following legalization in Canada. Even if full legal status does not come soon, both hemp and CBD-related products alone should allow for massive growth across the U.
With its specialty in cannabis oils, CannTrust should benefit. The company also expanded into Europe by becoming the first and only foreign seller of cannabis oil in Denmark beginning in October. At this moment, most cannabis equities could be described as high-growth stocks. QCOM stock has suffered in recent years. A long-running legal dispute with Apple has resulted in the exclusion of Qualcomm chips from the later models of the iPhone.
This and other legal battles regarding its licensing practices have weighted on QCOM. However, a great deal of anticipation surrounds its 5G-capable Snapdragon chip. Carriers have begun to launch 5G networks, and most expect 5G capable phones to see a wide release beginning later this year. AbbVie 1 is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases.
AbbVie's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus HCV and human immunodeficiency virus HIV ; neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions.
AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neurology, with additional targeted investment in cystic fibrosis and women's health. AbbVie was incorporated in Delaware on April 10, You have selected to change your default setting for the Quote Search.
Health Care Community Rating: Edit Symbol List Symbol Lookup. Go Now Clear List. Key Stock Data 1 Year Target.
AbbVie Inc. Common Stock (ABBV) Quote & Summary Data
Stock analysis for AbbVie Inc (ABBV:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AbbVie Inc. (AbbVie), incorporated on April 10, , is a research-based biopharmaceutical company. The Company is engaged in the discovery, development. AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a.